{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:17:01Z","timestamp":1790381821459,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/igo\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.vaccine.2023.09.048","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T05:28:11Z","timestamp":1697174891000},"page":"S107-S117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"S1","title":["Country ownership as a guiding principle for IA2030: A case study of the measles and rubella elimination programs in Nepal and Nigeria"],"prefix":"10.1016","volume":"42","author":[{"given":"Chizoba","family":"Wonodi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Crowcroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anindya Sekhar","family":"Bose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Oteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Momoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Shet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhalak Sharma","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Eudes","family":"Jean Baptiste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhir","family":"Khanal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balcha","family":"Masresha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Linstrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.09.048_b0005","unstructured":"WHO, \u201cImmunization Agenda 2030,\u201d 2019. [Online]. Available: https:\/\/www.who.int\/immunization\/ia2030_Draft_One_English.pdf?ua=1."},{"key":"10.1016\/j.vaccine.2023.09.048_b0010","doi-asserted-by":"crossref","unstructured":"Global Vaccine Action Plan. Vaccine, vol. 31, pp. B5\u2013B31, 2013, doi: 10.1016\/j.vaccine.2013.02.015.","DOI":"10.1016\/j.vaccine.2013.02.015"},{"key":"10.1016\/j.vaccine.2023.09.048_b0015","doi-asserted-by":"crossref","unstructured":"Development Assistance Committee. The Paris declaration on aid effectiveness and the Accra Agenda for action. Paris, Fr. Organ. Econ. \u2026, no. 2005, p. 21, 2008, http:\/\/doi.org\/10.1787\/9789264098107-en.","DOI":"10.1787\/9789264098107-en"},{"issue":"2","key":"10.1016\/j.vaccine.2023.09.048_b0020","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1377\/hlthaff.2015.1418","article-title":"Country ownership and gavi transition: Comprehensive approaches to supporting new vaccine introduction","volume":"35","author":"Shen","year":"2016","journal-title":"Health Affairs"},{"key":"10.1016\/j.vaccine.2023.09.048_b0025","doi-asserted-by":"crossref","unstructured":"Lindstrand A, Cherian T, Chang-Blanc D, Feikin D, O\u2019Brien KL. J Infect Dis. Volume 224, Issue Supplement_4, 1 October 2021, Pages S452\u2013S467, https:\/\/doi.org\/10.1093\/infdis\/jiab284.","DOI":"10.1093\/infdis\/jiab284"},{"key":"10.1016\/j.vaccine.2023.09.048_b0030","doi-asserted-by":"crossref","unstructured":"MacDonald N, Mohsni E, Al-Mazrou Y, Kim Andrus J, Arora N, Elden S, Madrid MY, Martin R, Mahmoud Mustafa A, Rees H, Salisbury D, Zhao Q, Jones I, Steffen CA, Hombach J, O'Brien KL, Cravioto A. Global vaccine action plan lessons learned I: Recommendations for the next decade. Vaccine. 2020 Jul 14;38(33):5364\u20135371. http:\/\/doi.org\/10.1016\/j.vaccine.2020.05.003. Epub 2020 May 5. PMID: 32563607; PMCID: PMC.","DOI":"10.1016\/j.vaccine.2020.05.003"},{"key":"10.1016\/j.vaccine.2023.09.048_b0035","doi-asserted-by":"crossref","unstructured":"Ophori EA, Tula MY, Azih AV, Okojie R, Ikpo PE. Current trends of immunization in Nigeria: prospect and challenges. Trop Med Health. 2014 Jun;42(2):67\u201375. http:\/\/doi.org\/10.2149\/tmh.2013-13. Epub 2014 Apr 23. PMID: 25237283; PMCID: PMC4139536.","DOI":"10.2149\/tmh.2013-13"},{"key":"10.1016\/j.vaccine.2023.09.048_b0040","article-title":"100214","volume":"2590\u20131362","author":"Hester","year":"2022","journal-title":"ISSN"},{"key":"10.1016\/j.vaccine.2023.09.048_b0045","unstructured":"Watson-Grant S, Xiong K, Thomas JC. Country Ownership in International Development: Toward a Working Definition. Work Pap. no. May, 2016, [Online]. Available: internal-pdf:\/\/241.243.36.75\/Watson-Grant-2016-Country Ownership in Interna.pdf."},{"key":"10.1016\/j.vaccine.2023.09.048_b0050","doi-asserted-by":"crossref","unstructured":"Frieden TR. Six components necessary for effective public health program implementation. Am J Publ Health, vol. 104, no. 1, 2014, http:\/\/doi.org\/10.2105\/AJPH.2013.301608.","DOI":"10.2105\/AJPH.2013.301608"},{"key":"10.1016\/j.vaccine.2023.09.048_b0055","unstructured":"Annual Report Department of Health Services 2074\/75. Kathmandu, 2018. [Online]. Available: https:\/\/dohs.gov.np\/wp-content\/uploads\/2019\/07\/Annual_Report_2074-751.pdf."},{"key":"10.1016\/j.vaccine.2023.09.048_b0060","unstructured":"The Sabin Vaccine Institute. Nepal Enacts Bill to Strengthen National Immunization Program, Reduce Dependency on External Funding | Sabin. Feb. 03, 2016. https:\/\/www.sabin.org\/updates\/pressreleases\/nepal-enacts-bill-strengthen-national-immunization-program-reduce-dependency (accessed Apr. 05, 2021)."},{"key":"10.1016\/j.vaccine.2023.09.048_b0065","unstructured":"Comprehensive Multi-Year Plan 2073-2077 B.S. (2017 - 2021), National Immunization Program, Nepal. Child Health Division Department of Health Services Ministry of Health, Nepal, Kathmandu, 2016."},{"key":"10.1016\/j.vaccine.2023.09.048_b0070","doi-asserted-by":"crossref","unstructured":"Huang XX, Bose AS, Gupta BP, et al. Vaccine preventable diseases surveillance in Nepal: How much does it cost? Vaccine, vol. 39, no. 40, 2021, http:\/\/doi.org\/10.1016\/j.vaccine.2021.07.038.","DOI":"10.1016\/j.vaccine.2021.07.038"},{"key":"10.1016\/j.vaccine.2023.09.048_b0075","doi-asserted-by":"crossref","unstructured":"Rushton S, Devkota B. Choosing not to weaponize healthcare: politics and health service delivery during Nepal\u2019s civil war, 1996-2006. Med Confl Surviv. p. 1\u201320, 2020, http:\/\/doi.org\/10.1080\/13623699.2020.1794366.","DOI":"10.1080\/13623699.2020.1794366"},{"key":"10.1016\/j.vaccine.2023.09.048_b0080","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.inhe.2011.12.004","article-title":"The Maoist insurgency (1996\u20132006) and child health indicators in Nepal","volume":"4","author":"Partap","year":"2012","journal-title":"Int Health"},{"key":"10.1016\/j.vaccine.2023.09.048_b0085","unstructured":"Masresha et al. Measles elimination in the WHO African Region\u00a0: Progress and challenges. African Heal. Monit. 2015;vol. 6(no. 19)."},{"issue":"SI1","key":"10.1016\/j.vaccine.2023.09.048_b0090","doi-asserted-by":"crossref","first-page":"135","DOI":"10.29245\/2578-3009\/2018\/si.1120","article-title":"Progress Towards Measles Elimination in Nigeria: 2012\u20132016","volume":"2","author":"Masresha","year":"2018","journal-title":"J Immunol Sci"},{"key":"10.1016\/j.vaccine.2023.09.048_b0095","series-title":"2017\/2018 Measles Vaccination Campaign Report","author":"Abuja NPHCDA","year":"2018"},{"key":"10.1016\/j.vaccine.2023.09.048_b0100","unstructured":"Abuja NPHCDA. Nigeria Strategy For Immunization And Primary Health Care System Strengthening [NSIPSS] 2018-2028. Abuja, Nigeria, 2018. [Online]. Available: https:\/\/nigeriahealthwatch.com\/wp-content\/uploads\/bsk-pdf-manager\/2019\/09\/18.04.2018_Nigeria-Strategy-for-Immunization-and-PHC-Strengthening_3rd_Version-Final.pdf."},{"key":"10.1016\/j.vaccine.2023.09.048_b0105","unstructured":"Gavi Alliance Board Meeting 6-7 June 2018. Gavi the Vaccine Alliance, p. 34, 2018. [Online]. Available: https:\/\/www.gavi.org\/sites\/default\/files\/board\/minutes\/2018\/Board-2018-Mtg-01-Minutes.pdf."},{"key":"10.1016\/j.vaccine.2023.09.048_b0110","doi-asserted-by":"crossref","unstructured":"O\u2019connell M, Wonodi C. Routine Immunization Consultant Program in Nigeria: A Qualitative Review of a Country-Driven Management Approach for Health Systems Strengthening. 2016. [Online]. Available: www.ghspjournal.org.","DOI":"10.9745\/GHSP-D-15-00209"},{"issue":"20","key":"10.1016\/j.vaccine.2023.09.048_b0115","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1016\/j.vaccine.2022.02.057","article-title":"Nepal measles outbreak response immunization during COVID-19: A risk-based intervention strategy","volume":"40","author":"Bose","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.09.048_b0120","first-page":"209","article-title":"A Theory of Change for Guiding the Integration of Human-Centered Design Into","volume":"9","author":"Lafond","year":"2021","journal-title":"Glob Health Programm"},{"key":"10.1016\/j.vaccine.2023.09.048_b0125","unstructured":"Measles & Rubella Initiative. Measles and Rubella Strategic Framework 2021-2030, 2021. [Online]. Available: https:\/\/s3.amazonaws.com\/wp-agility2\/measles\/wp-content\/uploads\/2020\/11\/measles_rubella_initiative_final_print.pdf."},{"key":"10.1016\/j.vaccine.2023.09.048_b0130","unstructured":"Initiatives to improve immunization in priority countries. https:\/\/www.who.int\/southeastasia\/activities\/initiatives-to-improve-immunization-in-priority-countries (accessed Apr. 14, 2021)."},{"key":"10.1016\/j.vaccine.2023.09.048_b0135","unstructured":"Nepal Issues Joint Statement to Eliminate Measles and Control Rubella\/CRS by 2019. A joint statement was signed on 18 September by representatives from each of these organizations in Kathmandu. Measles and Rubella Elimination Initiative, 2019. https:\/\/measlesrubellainitiative.org\/nepal-issues-joint-statement-eliminate-measles-control-rubellacrs-2019\/#comments."},{"key":"10.1016\/j.vaccine.2023.09.048_b0140","unstructured":"National Routine Immunization Strategic Plan 2013-2015. Federal Ministry of Health National Primary Health Care Development Agency, Nigeria, Abuja, Nigeria, p. 68, 2012. [Online]. Available: https:\/\/www.nitag-resource.org\/sites\/default\/files\/2b302ead55915d61468ac747e2e437aee65871b1_1.pdf."},{"key":"10.1016\/j.vaccine.2023.09.048_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2021.02.068","article-title":"Ensuring accountability in implementation of supplementary immunisation activities: A case study of the 2017\/2018 measles vaccination campaign in Nigeria","author":"Momoh","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.09.048_b0150","unstructured":"Review of progress and way forward on measles and rubella elimination activities in the WHO South-East Asia Region. New Delhi: World Health Organization, Regional Office for South-East Asia; 2022. License: CC BY-NC-SA 3.0 IGO."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23011313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23011313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T05:22:26Z","timestamp":1728969746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23011313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":30,"alternative-id":["S0264410X23011313"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.09.048","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Country ownership as a guiding principle for IA2030: A case study of the measles and rubella elimination programs in Nepal and Nigeria","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.09.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 World Health Organization; licensee Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}